Clinical Outcomes and Hepatic Toxicity of Combined Intensity Modulated Radiotherapy and PD-1 Inhibitors in Child-Pugh Class B Advanced Hepatocellular Carcinoma
Combined IMRT and PD-1 inhibitors improved clinical outcomes with a comparable incidence of RIHT to radiotherapy alone in advanced HCC patients with CP-B. The individual combined IMRT and PD-1 inhibitors for CP-B could be cautiously applied weighing the survival benefits and the RIHT risks.
Authors
- Shenshen Chen (ORCID: https://orcid.org/0000-0003-0231-0638)
- Lijun Chen (ORCID: https://orcid.org/0000-0001-9374-6466)
- Min Liu (ORCID: https://orcid.org/0000-0002-5059-3743)
- Shi‐Xiong Liang
- Shichun Guan
- Jian-Xu Li (ORCID: https://orcid.org/0000-0002-5298-3673)
- Yi Wu
Institutions
- Guangxi Medical University (CN)
- Zhuzhou Central Hospital (CN)
Publication Details
- Journal
- ImmunoTargets and Therapy
- Published
- 2025-09-01
- DOI
- https://doi.org/10.2147/itt.s538796
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- Guangxi Medical University